Spinal Muscular Atrophy

Spinal Muscular Atrophy is a hereditary disease which cause weakness and wastage in the voluntary muscles of legs and arms of infants and children. This disorder is caused by an abnormal or missing gene known as survival motor neuron gene. There are 3 types of SMA; Type 1 is evident at birth or in first few weeks, Type 2 normally begins in 6 to 18 months and Type 3 usually shows in between 2 and 17 years of age. There is no cure of SMA, treatment mainly consists of management of symptoms and prevention of complications. Researchers have started doing work in the field of strategies to cope up with SMA. The US FDA have approved nusinersen (brand name Spinzara) to carry out treatment of SMA on Dec. 23, 2016.

  • Track 1-1 Hereditary Disease
  • Track 2-2 Abnormal Missing Gene
  • Track 3-3 Types and Affecting Targets
  • Track 4-4 Dealing with Patients having SMA
  • Track 5-5 Recent Research on SMA

Related Conference of Neuroscience